GlassScriptPhysician profile
David B Kaplansky
NPI 1093821571
$8,965.90
in general payments reported to CMS, 2019-2025
47 companies · $920 in 2025
The $920 reported for 2025 was more than what 79% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,849 · 2020: $326 · 2021: $870 · 2022: $2,044 · 2023: $1,915 · 2024: $1,042 · 2025: $920.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,219 · Travel and Lodging: $658.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,219.07 |
| Travel and Lodging | $657.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $3,031.63 | 2019-2024 | |
| Paragon 28, INC. | $985.27 | 2019-2024 | Apex 3d, Portfolio, Smart Lapidus |
| Smith+Nephew, INC. | $688.23 | 2019-2025 | Grafix Pl, Renasys Go V2 Home, Stravix Mesh |
| Paratek Pharmaceuticals, INC. | $532.82 | 2021-2025 | Nuzyra |
| Globus Medical, INC. | $414.53 | 2023-2025 | Senza, Ankle Fracture System, Ossifuse |
| Horizon Therapeutics Plc | $394.97 | 2019-2023 | Krystexxa |
| Nevro Corp. | $326.48 | 2022-2024 | Senza |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $226.74 | 2020-2024 | Jublia |
| Stryker Corporation | $221.23 | 2019-2025 | |
| Melinta Therapeutics, LLC | $181.47 | 2019-2023 | Kimyrsa |
| Ortho Solutions INC | $171.25 | 2024-2025 | |
| Medtronic, INC. | $170.48 | 2023-2025 | Inceptiv, Intellis Adaptivestim |
| Kowa Pharmaceuticals America, INC. | $148.37 | 2022-2023 | Seglentis |
| Organogenesis INC. | $147.27 | 2023 | Puraply |
| Extremity Medical | $136.26 | 2024 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $114.43 | 2024 | |
| Convatec INC. | $99.66 | 2023-2024 | |
| Nabriva Therapeutics, Plc | $96.87 | 2021-2022 | |
| Bioventus LLC | $80.35 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Amgen INC. | $78.50 | 2024-2025 | Krystexxa |
| Vaporox, INC. | $72.67 | 2023 | Vht-200 Wound Treatment System |
| Sandoz INC. | $53.40 | 2019-2020 | |
| Trice Medical, INC. | $49.68 | 2021 | |
| Fidia Pharma USA INC. | $49.28 | 2019-2024 | Hyalgan, Triluron, Hymovis |
| Tactile Systems Technology INC | $40.58 | 2020-2022 | |
| Sebela Pharmaceuticals INC. | $38.82 | 2021-2022 | |
| Ani Pharmaceuticals, INC. | $33.98 | 2024-2025 | Purified Cortrophin Gel |
| Kerecis Limited | $27.81 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $27.47 | 2019 | |
| Merck Sharp & Dohme LLC | $27.14 | 2019 | |
| Stimwave Technologies Incorporated | $26.64 | 2022 | |
| Orthofix Medical, INC. | $26.23 | 2019-2022 | |
| Triad Life Sciences INC. | $21.00 | 2022 | |
| Bsn Medical INC | $20.82 | 2019 | |
| Abbott Laboratories | $18.50 | 2021 | |
| Pfizer INC. | $17.88 | 2019 | |
| Mckesson Medical-Surgical, INC. | $17.41 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $17.30 | 2025 | |
| Inari Medical, INC. | $16.92 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Zimmer Biomet Holdings, INC. | $16.79 | 2021 | |
| In2bones USA, LLC | $16.45 | 2019 | |
| Celularity INC. | $16.00 | 2019 | |
| Amniox Medical, INC. | $15.37 | 2019 | |
| Baudax Bio INC. | $15.22 | 2021 | |
| Arthrosurface Incorporated | $13.99 | 2019 | |
| Axogen | $11.49 | 2021 | |
| Arteriocyte Medical Systems, INC. | $10.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kaplansky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.